Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals

<p>Abstract</p> <p>Background</p> <p>The first line anti-tuberculosis drugs isoniazid (INH), rifampicin (RIF) and pyrazinamide (PZA) continues to be the effective drugs in the treatment of tuberculosis, however, the use of these drugs is associated with toxic reactions...

Full description

Bibliographic Details
Main Authors: Izzettin Fikret V, Uraz Fikriye, Eminzade Sude
Format: Article
Language:English
Published: BMC 2008-07-01
Series:Nutrition & Metabolism
Online Access:http://www.nutritionandmetabolism.com/content/5/1/18

Similar Items

Similar Items